default author photo

Haitao Wang

Government of the United States of America - Thoracic Surgery Branch

SCHOLARLY PAPERS

2

DOWNLOADS

198

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Selective Small Molecule Activation of Mannose Receptor CD206 Recalibrates Macrophage Function to Improve Outcomes of Cancer and Inflammatory Diseases

Number of pages: 169 Posted: 09 Sep 2025
Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - Thoracic Surgery Branch, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Nagoya City University - Graduate School of Medical Sciences, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - Laboratory of Immune System Biology, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - Laboratory of Immune System Biology, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Nagoya City University - Graduate School of Medical Sciences, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Cancer Institute and Independent
Downloads 116 (621,896)

Abstract:

Loading...

mannose receptor 1 (MRC1, CD206), CD206 small molecule agonist, tumor associated macrophages, innate immune indolence, macrophage epigenome, CD206 glycosylation, retinal fibrosis, non-alcoholic steatohepatitis (NASH)

2.

Machine Learning Based on Blood Test Biomarkers Predicts Fast Progression in Advanced NSCLC Patients Treated with Immunotherapy

Number of pages: 20 Posted: 09 Sep 2022
Zunyi Medical University - Department of Oncology, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Government of the United States of America - Thoracic Surgery Branch, University of Macau, Harrisburg University of Science and Technology - Department of Analytics, Sanofi - New Jersey - Department of Biostat & Programming, Zunyi Medical University - Department of Oncology, Zunyi Medical University - Department of Oncology, Zunyi Medical University - Department of Oncology, University Hospital Erlangen - Translational Radiobiology, University Hospital Erlangen - Department of Radiation Oncology, University Hospital Erlangen - Department of Radiation Oncology, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Zunyi Medical University - Department of Oncology and University Hospital Erlangen - Translational Radiobiology
Downloads 82 (790,029)

Abstract:

Loading...

Machine Learning, Blood Test Biomarkers, Fast Progression, NSCLC, Immunotherapy, Immune checkpoint inhibitor